Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1951-1960 of 2244 for

Edit search filters
  1. Preclinical investigation of immunotherapeutic efficacy and safety of a novel oncolytic vesicular stomatitis virus expressing extracellular matrix-destructing enzymes in combination with immune checkpoint inhibitors in pancreatic adenocarcinoma

    Jacksonville, FL

  2. Interviews About Social Determinants of Health in Southeast Asian Americans to Identify Liver Cancer Disparities

    Rochester, MN

  3. Manufacturing Outcomes with Patient Factors from Multiple Myeloma Patients Prescribed Ciltacabtagene Autoleucel

    Rochester, MN

  4. A2B101-101: Obtaining Solid Tumor Tissue from Subjects Having Surgical Resection for Certain Tumor Types and Leukapheresis for CAR T-cell Therapy Manufacturing

    Rochester, MN, Jacksonville, FL, Scottsdale/Phoenix, AZ

  5. Localized Leiomyosarcoma Biomarker Protocol

    Rochester, MN

  6. MC240508: Genomic Surveillance of Bladder Cancer

    Scottsdale/Phoenix, AZ

  7. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program

    Rochester, MN

  8. Recruitment to Promote Cancer Health Equity Across Florida

    Jacksonville, FL

  9. MRI Techniques for early-stage detection of cancer

    Rochester, MN

  10. Asynchronous Skin Cancer Risk Using 3D Total-Body Photograph

    Rochester, MN

.

Mayo Clinic Footer